Scabies.
Journal
Nature reviews. Disease primers
ISSN: 2056-676X
Titre abrégé: Nat Rev Dis Primers
Pays: England
ID NLM: 101672103
Informations de publication
Date de publication:
03 Oct 2024
03 Oct 2024
Historique:
accepted:
22
08
2024
medline:
4
10
2024
pubmed:
4
10
2024
entrez:
3
10
2024
Statut:
epublish
Résumé
Scabies is one of the most common and highest-burden skin diseases globally. Estimates suggest that >200 million people worldwide have scabies at any one time, with an annual prevalence of 455 million people, with children in impoverished and overcrowded settings being the most affected. Scabies infection is highly contagious and leads to considerable morbidity. Secondary bacterial infections are common and can cause severe health complications, including sepsis or necrotizing soft-tissue infection, renal damage and rheumatic heart disease. There is no vaccine or preventive treatment against scabies and, for the past 30 years, only few broad-spectrum antiparasitic drugs (mainly topical permethrin and oral ivermectin) have been widely available. Treatment failure is common because drugs have short half-lives and do not kill all developmental stages of the scabies parasite. At least two consecutive treatments are needed, which is difficult to achieve in resource-poor and itinerant populations. Another key issue is the lack of a practical, rapid, cheap and accurate diagnostic tool for the timely detection of scabies, which could prevent the cycle of exacerbation and disease persistence in communities. Scabies control will require a multifaceted approach, aided by improved diagnostics and surveillance, new treatments, and increased public awareness.
Identifiants
pubmed: 39362885
doi: 10.1038/s41572-024-00552-8
pii: 10.1038/s41572-024-00552-8
doi:
Substances chimiques
Ivermectin
70288-86-7
Antiparasitic Agents
0
Permethrin
509F88P9SZ
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
74Informations de copyright
© 2024. Springer Nature Limited.
Références
Fischer, K. & Chosidow, O. Scabies (Springer, 2023). This book covers the current status quo in scabies research.
Karimkhani, C. et al. The global burden of scabies: a cross-sectional analysis from the Global Burden of Disease Study 2015. Lancet Infect. Dis. 17, 1247–1254 (2017). Unsurpassed analysis and documentation of the global morbidity and burden of scabies.
pubmed: 28941561
pmcid: 5700804
doi: 10.1016/S1473-3099(17)30483-8
Hay, R. J. et al. The global burden of skin disease in 2010: an analysis of the prevalence and impact of skin conditions. J. Invest. Dermatol. 134, 1527–1534 (2014). Important paper providing an analysis of the global burden of skin disease.
pubmed: 24166134
doi: 10.1038/jid.2013.446
World Health Organization. WHO Informal Consultation on a Framework for Scabies Control (WHO, 2019).
Bornstein, S., Mörner, T. & Samuel, W. M. in Parasitic Diseases of Wild Mammals (eds Samuel, W. M., Pybus, M. J. & Kocan, A. A.) 107–119 (Iowa State University Press, 2001).
Kraabøl, M., Gundersen, V., Fangel, K. & Olstad, K. The taxonomy, life cycle and pathology of Sarcoptes scabiei and Notoedres cati (Acarina, Sarcoptidae): a review in a Fennoscandian wildlife perspective. Fauna Nor. 35, 21 (2015).
doi: 10.5324/fn.v35i0.1652
Roberts, L. J., Huffam, S. E., Walton, S. F. & Currie, B. J. Crusted scabies: clinical and immunological findings in seventy-eight patients and a review of the literature. J. Infect. 50, 375–381 (2005).
pubmed: 15907543
doi: 10.1016/j.jinf.2004.08.033
Smith, H. J. Transmission of Sarcoptes scabiei in swine by fomites. Can. Vet. J. 27, 252–254 (1986).
pubmed: 17422671
pmcid: 1680258
Mellanby, K. Transmission of scabies. Br. Med. J. 2, 405–406 (1941).
pubmed: 20783868
pmcid: 2162942
doi: 10.1136/bmj.2.4211.405
Bernigaud, C., Fischer, K. & Chosidow, O. The management of scabies in the 21st century: past, advances and potentials. Acta Derm. Venereol. 100, adv00112 (2020).
pubmed: 32207535
doi: 10.2340/00015555-3468
Slape, D., Russell, R. & McMeniman, E. in Scabies (eds Fischer, K. & Chosidow, O.) 233–268 (Springer, 2023).
Skayem, C. et al. Severe scabies: a French multi-centre study involving 95 patients with crusted and profuse disease and review of the literature. Acta Derm. Venereol. 103, adv00878 (2023).
pubmed: 36861856
doi: 10.2340/actadv.v103.5351
Niode, N. J. et al. Crusted scabies, a neglected tropical disease: case series and literature review. Infect. Dis. Rep. 14, 479–491 (2022).
pubmed: 35735761
pmcid: 9223105
doi: 10.3390/idr14030051
Moroni, B., Rossi, L., Bernigaud, C. & Guillot, J. Zoonotic episodes of scabies: a global overview. Pathogens 11, 213 (2022).
pubmed: 35215156
pmcid: 8877739
doi: 10.3390/pathogens11020213
Lynar, S., Currie, B. J. & Baird, R. Scabies and mortality. Lancet Infect. Dis. 17, 1234 (2017). This short correspondence discusses the substantial global mortality burden from scabies, in addition to the recognised morbidity.
pubmed: 29173877
doi: 10.1016/S1473-3099(17)30636-9
del Giudice, P., Sainte Marie, D., Gérard, Y., Couppié, P. & Pradinaud, R. Is crusted (Norwegian) scabies a marker of adult T cell leukemia/lymphoma in human T lymphotropic virus type I-seropositive patients? J. Infect. Dis. 176, 1090–1092 (1997).
pubmed: 9333174
doi: 10.1086/516518
Scabies — level 3 cause. IHME https://www.healthdata.org/research-analysis/diseases-injuries-risks/factsheets/2021-scabies-level-3-disease (2020).
Romani, L., Steer, A. C., Whitfeld, M. J. & Kaldor, J. M. Prevalence of scabies and impetigo worldwide: a systematic review. Lancet Infect. Dis. 15, 960–967 (2015). This article summarizes population-based studies that reported on the overlapping prevalence of scabies and impetigo.
pubmed: 26088526
doi: 10.1016/S1473-3099(15)00132-2
Zhang, W. et al. Trends in prevalence and incidence of scabies from 1990 to 2017: findings from the Global Burden of Disease study 2017. Emerg. Microbes Infect. 9, 813–816 (2020).
pubmed: 32284022
pmcid: 7241492
doi: 10.1080/22221751.2020.1754136
Currie, B. J. & Carapetis, J. R. Skin infections and infestations in Aboriginal communities in northern Australia. Australas. J. Dermatol. 41, 139–143 (2000).
pubmed: 10954983
doi: 10.1046/j.1440-0960.2000.00417.x
Amoako, Y. A. et al. A scabies outbreak in the North East Region of Ghana: the necessity for prompt intervention. PLoS Negl. Trop. Dis. 14, e0008902 (2020).
pubmed: 33351803
pmcid: 7787682
doi: 10.1371/journal.pntd.0008902
Schneider, S., Wu, J., Tizek, L., Ziehfreund, S. & Zink, A. Prevalence of scabies worldwide — an updated systematic literature review in 2022. J. Eur. Acad. Dermatol. Venereol. 37, 1749–1757 (2023).
pubmed: 37147907
doi: 10.1111/jdv.19167
Enbiale, W. & Ayalew, A. Investigation of a scabies outbreak in drought-affected areas in Ethiopia. Trop. Med. Infect. Dis. 3, 114 (2018).
pubmed: 30380650
pmcid: 6306922
doi: 10.3390/tropicalmed3040114
Delaš Aždajić, M. et al. Increased scabies incidence at the beginning of the 21st century: what do reports from Europe and the world show? Life 12, 1598 (2022).
doi: 10.3390/life12101598
Donà, M. G. et al. Increasing trend in confirmed scabies cases in the only public dermatological institute of scientific research and care in Italy. Eur. J. Dermatol. 33, 709–710 (2023).
pubmed: 38465564
doi: 10.1684/ejd.2023.4622
Richardson, N. A. et al. Scabies outbreak management in refugee/migrant camps in Europe 2014-2017: a retrospective qualitative interview study of healthcare staff experiences and perspectives. BMJ Open 13, e075103 (2023).
pubmed: 37940153
pmcid: 10632829
doi: 10.1136/bmjopen-2023-075103
Abdolrasouli, A., Cousins, C. D., Basu, T. N., Trotman, D. & Hay, R. J. Permethrin-unresponsive scabies in London, UK: a wake-up call. Clin. Exp. Dermatol. 48, 1280–1282 (2023).
pubmed: 37539683
doi: 10.1093/ced/llad259
Khan, S. S. & Fuller, L. C. Is there a growing global threat of scabies treatment failure? An opportunity to discuss health inequity within UK dermatology. Br. J. Dermatol. 190, 139–140 (2024).
pubmed: 37976288
doi: 10.1093/bjd/ljad457
Skin and subcutaneous diseases — level 2 cause. IHME https://www.healthdata.org/research-analysis/diseases-injuries-risks/factsheets/2021-skin-and-subcutaneous-diseases-level-2 (2020).
Lopes, M. J. et al. Perceptions, attitudes and practices towards scabies in communities on the Bijagos Islands, Guinea-Bissau. Trans. R. Soc. Trop. Med. Hyg. 114, 49–56 (2020).
pubmed: 31722016
Sara, J., Haji, Y. & Gebretsadik, A. Scabies outbreak investigation and risk factors in East Badewacho District, southern Ethiopia: unmatched case control study. Dermatol. Res. Pract. 2018, 7276938 (2018).
pubmed: 30046302
pmcid: 6038489
doi: 10.1155/2018/7276938
Scabies. CDC https://www.cdc.gov/scabies/prevention/index.html (2024).
Talukder, K. et al. Controlling scabies in madrasahs (Islamic religious schools) in Bangladesh. Public Health 127, 83–91 (2013).
pubmed: 23062631
doi: 10.1016/j.puhe.2012.09.004
Kouotou, E. A. et al. Burden of human scabies in sub-Saharan African prisons: evidence from the west region of Cameroon. Australas. J. Dermatol. 59, e6–e10 (2018).
pubmed: 28251621
doi: 10.1111/ajd.12540
Cassell, J. A. et al. Scabies outbreaks in ten care homes for elderly people: a prospective study of clinical features, epidemiology, and treatment outcomes. Lancet Infect. Dis. 18, 894–902 (2018).
pubmed: 30068499
pmcid: 6060176
doi: 10.1016/S1473-3099(18)30347-5
Raffi, J., Suresh, R. & Butler, D. C. Review of scabies in the elderly. Dermatol. Ther. 9, 623–630 (2019).
doi: 10.1007/s13555-019-00325-2
Rahman, M. S., Hasan, A. B. M. N., Jahan, I. & Sharif, A. B. Prevalence of scabies and its associated environmental risk factors among the forcibly displaced Myanmar nationals living in the Cox’s Bazar district of Bangladesh. J. Migr. Health 9, 100220 (2024).
pubmed: 39263380
pmcid: 11390180
doi: 10.1016/j.jmh.2024.100220
Thornton, J. Scabies in Cox’s Bazar. Lancet 402, 600 (2023).
pubmed: 37598683
doi: 10.1016/S0140-6736(23)01731-2
Engelman, D. et al. Toward the global control of human scabies: introducing the International Alliance for the Control of Scabies. PLoS Negl. Trop. Dis. 7, e2167 (2013). This paper describes a global initiative with the shared objective to foster research, treatment and diagnosis, and to control and, where possible, eliminate infections caused by Sarcoptes scabiei.
pubmed: 23951369
pmcid: 3738445
doi: 10.1371/journal.pntd.0002167
Engelman, D. et al. The public health control of scabies: priorities for research and action. Lancet 394, 81–92 (2019).
pubmed: 31178154
pmcid: 11257500
doi: 10.1016/S0140-6736(19)31136-5
Hoy, W. E. et al. Post-streptococcal glomerulonephritis is a strong risk factor for chronic kidney disease in later life. Kidney Int. 81, 1026–1032 (2012).
pubmed: 22297679
doi: 10.1038/ki.2011.478
Carapetis, J. R., Steer, A. C., Mulholland, E. K. & Weber, M. The global burden of group A streptococcal diseases. Lancet Infect. Dis. 5, 685–694 (2005).
pubmed: 16253886
doi: 10.1016/S1473-3099(05)70267-X
Rheumatic heart disease — level 3 cause. IHME https://www.healthdata.org/research-analysis/diseases-injuries-risks/factsheets/2021-rheumatic-heart-disease-level-3-disease (2020).
Acute glomerulonephritis — level 3 cause. IHME https://www.healthdata.org/research-analysis/diseases-injuries-risks/factsheets/2021-acute-glomerulonephritis-level-3-disease (2020).
Van Neste, D. Behaviour of Sarcoptes scabiei in its burrow in hyperkeratotic scabies. Dermatologica 171, 343–348 (1985).
pubmed: 3935495
doi: 10.1159/000249449
Beckham, S. A. et al. Characterization of a serine protease homologous to house dust mite group 3 allergens from the scabies mite Sarcoptes scabiei. J. Biol. Chem. 284, 34413–34422 (2009).
pubmed: 19812030
pmcid: 2797209
doi: 10.1074/jbc.M109.061911
Mahmood, W., Viberg, L. T., Fischer, K., Walton, S. F. & Holt, D. C. An aspartic protease of the scabies mite Sarcoptes scabiei is involved in the digestion of host skin and blood macromolecules. PLoS Negl. Trop. Dis. 7, e2525 (2013).
pubmed: 24244770
pmcid: 3820722
doi: 10.1371/journal.pntd.0002525
Fernando, D. D. & Fischer, K. Proteases and pseudoproteases in parasitic arthropods of clinical importance. FEBS J. 287, 4284–4299 (2020).
pubmed: 32893448
doi: 10.1111/febs.15546
Korhonen, P. K. et al. High-quality nuclear genome for Sarcoptes scabiei — a critical resource for a neglected parasite. PLoS Negl. Trop. Dis. 14, e0008720 (2020). This paper reports high-quality genome and transcriptome data for S. scabiei.
pubmed: 33001992
pmcid: 7591027
doi: 10.1371/journal.pntd.0008720
Fischer, K., Holt, D., Currie, B. & Kemp, D. Scabies: important clinical consequences explained by new molecular studies. Adv. Parasitol. 79, 339–373 (2012).
pubmed: 22726646
doi: 10.1016/B978-0-12-398457-9.00005-6
Holt, D. C., Burgess, S. T., Reynolds, S. L., Mahmood, W. & Fischer, K. Intestinal proteases of free-living and parasitic astigmatid mites. Cell Tissue Res. 351, 339–352 (2013).
pubmed: 22427061
doi: 10.1007/s00441-012-1369-9
Bergstrom, F. C. et al. Scabies mite inactivated serine protease paralogs inhibit the human complement system. J. Immunol. 182, 7809–7817 (2009).
pubmed: 19494305
doi: 10.4049/jimmunol.0804205
Reynolds, S. L. et al. Scabies mite inactive serine proteases are potent inhibitors of the human complement lectin pathway. PLoS Negl. Trop. Dis. 8, e2872 (2014).
pubmed: 24854034
pmcid: 4031079
doi: 10.1371/journal.pntd.0002872
Swe, P. M., Christian, L. D., Lu, H. C., Sriprakash, K. S. & Fischer, K. Complement inhibition by Sarcoptes scabiei protects Streptococcus pyogenes — an in vitro study to unravel the molecular mechanisms behind the poorly understood predilection of S. pyogenes to infect mite-induced skin lesions. PLoS Negl. Trop. Dis. 11, e0005437 (2017).
pubmed: 28278252
pmcid: 5360341
doi: 10.1371/journal.pntd.0005437
Swe, P. M. & Fischer, K. A scabies mite serpin interferes with complement-mediated neutrophil functions and promotes staphylococcal growth. PLoS Negl. Trop. Dis. 8, e2928 (2014).
pubmed: 24945501
pmcid: 4063749
doi: 10.1371/journal.pntd.0002928
Mika, A. et al. Complement inhibitors from scabies mites promote streptococcal growth — a novel mechanism in infected epidermis? PLoS Negl. Trop. Dis. 6, e1563 (2012).
pubmed: 22815998
pmcid: 3398963
doi: 10.1371/journal.pntd.0001563
Terao, Y. et al. Group A streptococcal cysteine protease degrades C3 (C3b) and contributes to evasion of innate immunity. J. Biol. Chem. 283, 6253–6260 (2008).
pubmed: 18160402
doi: 10.1074/jbc.M704821200
Fernie-King, B. A. et al. Streptococcal inhibitor of complement (SIC) inhibits the membrane attack complex by preventing uptake of C567 onto cell membranes. Immunology 103, 390–398 (2001).
pubmed: 11454069
pmcid: 1783247
doi: 10.1046/j.1365-2567.2001.01249.x
Langley, R. et al. The staphylococcal superantigen-like protein 7 binds IgA and complement C5 and inhibits IgA-FcαRI binding and serum killing of bacteria. J. Immunol. 174, 2926–2933 (2005).
pubmed: 15728504
doi: 10.4049/jimmunol.174.5.2926
Ramsland, P. A. et al. Structural basis for evasion of IgA immunity by Staphylococcus aureus revealed in the complex of SSL7 with Fc of human IgA1. Proc. Natl Acad. Sci. USA 104, 15051–15056 (2007).
pubmed: 17848512
pmcid: 1986611
doi: 10.1073/pnas.0706028104
Hallstrom, T., Jarva, H., Riesbeck, K. & Blom, A. M. Interaction with C4b-binding protein contributes to nontypeable Haemophilus influenzae serum resistance. J. Immunol. 178, 6359–6366 (2007).
pubmed: 17475865
doi: 10.4049/jimmunol.178.10.6359
Hallstrom, T. et al. Haemophilus influenzae interacts with the human complement inhibitor factor H. J. Immunol. 181, 537–545 (2008).
pubmed: 18566420
doi: 10.4049/jimmunol.181.1.537
Rooijakkers, S. H. & van Strijp, J. A. Bacterial complement evasion. Mol. Immunol. 44, 23–32 (2007).
pubmed: 16875737
doi: 10.1016/j.molimm.2006.06.011
Akesson, P., Sjoholm, A. G. & Bjorck, L. Protein SIC, a novel extracellular protein of Streptococcus pyogenes interfering with complement function. J. Biol. Chem. 271, 1081–1088 (1996).
pubmed: 8557634
doi: 10.1074/jbc.271.2.1081
Bisno, A. L., Brito, M. O. & Collins, C. M. Molecular basis of group A streptococcal virulence. Lancet Infect. Dis. 3, 191–200 (2003).
pubmed: 12679262
doi: 10.1016/S1473-3099(03)00576-0
Laarman, A. J. et al. Staphylococcus aureus metalloprotease aureolysin cleaves complement C3 to mediate immune evasion. J. Immunol. 186, 6445–6453 (2011).
pubmed: 21502375
doi: 10.4049/jimmunol.1002948
Laarman, A., Milder, F., van Strijp, J. & Rooijakkers, S. Complement inhibition by gram-positive pathogens: molecular mechanisms and therapeutic implications. J. Mol. Med. 88, 115–120 (2010).
pubmed: 20062962
doi: 10.1007/s00109-009-0572-y
Rooijakkers, S. H. et al. Early expression of SCIN and CHIPS drives instant immune evasion by Staphylococcus aureus. Cell Microbiol. 8, 1282–1293 (2006).
pubmed: 16882032
doi: 10.1111/j.1462-5822.2006.00709.x
Ermert, D. et al. Virulence of group A streptococci is enhanced by human complement inhibitors. PLoS Pathog. 11, e1005043 (2015).
pubmed: 26200783
pmcid: 4511809
doi: 10.1371/journal.ppat.1005043
Foster, T. J. Immune evasion by staphylococci. Nat. Rev. Microbiol. 3, 948–958 (2005).
pubmed: 16322743
doi: 10.1038/nrmicro1289
Hasan, T., Krause, V. L., James, C. & Currie, B. J. Crusted scabies; a 2-year prospective study from the Northern Territory of Australia. PLoS Negl. Trop. Dis. 14, e0008994 (2020).
pubmed: 33338053
pmcid: 7781478
doi: 10.1371/journal.pntd.0008994
Bhat, S. A. et al. Early immune suppression leads to uncontrolled mite proliferation and potent host inflammatory responses in a porcine model of crusted versus ordinary scabies. PLoS Negl. Trop. Dis. 14, e0008601 (2020).
pubmed: 32886659
pmcid: 7508399
doi: 10.1371/journal.pntd.0008601
Elwood, H., Berry, R. S., Gardner, J. M. & Shalin, S. C. Superficial fibrin thrombi… and other findings: a review of the histopathology of human scabietic infections. J. Cutan. Pathol. 42, 346–352 (2015).
pubmed: 25754497
doi: 10.1111/cup.12482
Fernando, D. D. et al. A unique group of scabies mite pseudoproteases promotes cutaneous blood coagulation and delays plasmin-induced fibrinolysis. PLoS Negl. Trop. Dis. 15, e0008997 (2021).
pubmed: 33406071
pmcid: 7815109
doi: 10.1371/journal.pntd.0008997
Fernando, D. D. et al. Phylogenetic relationships, stage-specific expression and localisation of a unique family of inactive cysteine proteases in Sarcoptes scabiei. Parasit. Vectors 11, 301 (2018).
pubmed: 29769145
pmcid: 5956821
doi: 10.1186/s13071-018-2862-0
Arlian, L. G., Morgan, M. S. & Paul, C. C. Evidence that scabies mites (Acari: Sarcoptidae) influence production of interleukin-10 and the function of T-regulatory cells (Tr1) in humans. J. Med. Entomol. 43, 283–287 (2006).
pubmed: 16619612
doi: 10.1093/jmedent/43.2.283
Morgan, M. S. & Arlian, L. G. Response of human skin equivalents to Sarcoptes scabiei. J. Med. Entomol. 47, 877–883 (2010).
pubmed: 20939384
doi: 10.1093/jmedent/47.5.877
Elder, B. L., Arlian, L. G. & Morgan, M. S. Sarcoptes scabiei (Acari: Sarcoptidae) mite extract modulates expression of cytokines and adhesion molecules by human dermal microvascular endothelial cells. J. Med. Entomol. 43, 910–915 (2006).
pubmed: 17017228
doi: 10.1093/jmedent/43.5.910
Arlian, L. G., Fall, N. & Morgan, M. S. In vivo evidence that Sarcoptes scabiei (Acari: Sarcoptidae) is the source of molecules that modulate splenic gene expression. J. Med. Entomol. 44, 1054–1063 (2007).
pubmed: 18047206
doi: 10.1093/jmedent/44.6.1054
Bergamin, G., Hudson, J., Currie, B. J. & Mounsey, K. E. A systematic review of immunosuppressive risk factors and comorbidities associated with the development of crusted scabies. Int. J. Infect. Dis. 143, 107036 (2024).
pubmed: 38570134
doi: 10.1016/j.ijid.2024.107036
Mounsey, K. et al. A tractable experimental model for study of human and animal scabies. PLoS Negl. Trop. Dis. 4, e756 (2010). This paper describes the pig scabies model, which has enabled the development of comprehensive molecular databases.
pubmed: 20668508
pmcid: 2907415
doi: 10.1371/journal.pntd.0000756
Currie, B. J., Maguire, G. P. & Wood, Y. K. Ivermectin and crusted (Norwegian) scabies. Med. J. Aust. 163, 559–560 (1995).
pubmed: 8538537
doi: 10.5694/j.1326-5377.1995.tb124745.x
Mounsey, K. E. et al. Prospective study in a porcine model of Sarcoptes scabiei indicates the association of Th2 and Th17 pathways with the clinical severity of scabies. PLoS Negl. Trop. Dis. 9, e0003498 (2015).
pubmed: 25730203
pmcid: 4346266
doi: 10.1371/journal.pntd.0003498
Skerratt, L. F. Cellular response in the dermis of common wombats (Vombatus ursinus) infected with Sarcoptes scabiei var. wombati. J. Wildl. Dis. 39, 193–202 (2003).
pubmed: 12685083
doi: 10.7589/0090-3558-39.1.193
Walton, S. F., Beroukas, D., Roberts-Thomson, P. & Currie, B. J. New insights into disease pathogenesis in crusted (Norwegian) scabies: the skin immune response in crusted scabies. Br. J. Dermatol. 158, 1247–1255 (2008).
pubmed: 18422789
doi: 10.1111/j.1365-2133.2008.08541.x
Amer, M., Mostafa, F. F., Nasr, A. N. & el-Harras, M. The role of mast cells in treatment of scabies. Int. J. Dermatol. 34, 186–189 (1995).
pubmed: 7538495
doi: 10.1111/j.1365-4362.1995.tb01564.x
Nimmervoll, H. et al. Pathology of sarcoptic mange in red foxes (Vulpes vulpes): macroscopic and histologic characterization of three disease stages. J. Wildl. Dis. 49, 91–102 (2013).
pubmed: 23307375
doi: 10.7589/2010-11-316
Shehwana, H. et al. Transcriptome analysis of host inflammatory responses to the ectoparasitic mite Sarcoptes scabiei var. hominis. Front. Immunol. 12, 778840 (2021).
pubmed: 34925353
pmcid: 8671885
doi: 10.3389/fimmu.2021.778840
Bhat, S. A., Mounsey, K. E., Liu, X. & Walton, S. F. Host immune responses to the itch mite, Sarcoptes scabiei, in humans. Parasit. Vectors 10, 385 (2017).
pubmed: 28797273
pmcid: 5553898
doi: 10.1186/s13071-017-2320-4
Liu, X. et al. Crusted scabies is associated with increased IL-17 secretion by skin T cells. Parasite Immunol. 36, 594–604 (2014).
pubmed: 25040151
doi: 10.1111/pim.12129
Walton, S. F. et al. Increased allergic immune response to Sarcoptes scabiei antigens in crusted versus ordinary scabies. Clin. Vaccin. Immunol. 17, 1428–1438 (2010).
doi: 10.1128/CVI.00195-10
Rodriguez-Lago, L. & Borrego, L. Norwegian scabies in an atopic patient under dupilumab treatment. Dermatitis 33, e54–e55 (2022).
pubmed: 35943363
doi: 10.1097/DER.0000000000000926
Nwufoh, O. C., Sadiq, N. A., Adediran, O. A., Jarikre, T. A. & Emikpe, B. O. Sequential histopathological changes and cytokine expressions in dogs naturally infested with Sarcoptes scabiei mites. Acta Parasitol. 65, 452–461 (2020).
pubmed: 32100229
doi: 10.2478/s11686-020-00181-7
Rampton, M. et al. Antibody responses to Sarcoptes scabiei apolipoprotein in a porcine model: relevance to immunodiagnosis of recent infection. PLoS ONE 8, e65354 (2013).
pubmed: 23762351
pmcid: 3675102
doi: 10.1371/journal.pone.0065354
Boralevi, F. et al. Clinical phenotype of scabies by age. Pediatrics 133, e910–e916 (2014).
pubmed: 24685953
doi: 10.1542/peds.2013-2880
Sanders, K. M. et al. Non-histaminergic itch mediators elevated in the skin of a porcine model of scabies and of human scabies patients. J. Invest. Dermatol. 139, 971–973 (2019).
pubmed: 30395848
doi: 10.1016/j.jid.2018.09.032
Estrada-Chávez, G., Estrada, R., Engelman, D., Molina, J. & Chávez-López, G. Cushing syndrome due to inappropriate corticosteroid topical treatment of undiagnosed scabies. Trop. Med. Infect. Dis. 3, 82 (2018).
pubmed: 30274478
pmcid: 6161154
doi: 10.3390/tropicalmed3030082
Marlière, V., Roul, S., Labrèze, C. & Taïeb, A. Crusted (Norwegian) scabies induced by use of topical corticosteroids and treated successfully with ivermectin. J. Pediatr. 135, 122–124 (1999).
pubmed: 10393619
doi: 10.1016/S0022-3476(99)70342-2
Hashimoto, T., Satoh, T. & Yokozeki, H. Pruritus in ordinary scabies: IL-31 from macrophages induced by overexpression of thymic stromal lymphopoietin and periostin. Allergy 74, 1727–1737 (2019).
pubmed: 31087686
doi: 10.1111/all.13870
Bowen, A. C., Tong, S. Y. C., Chatfield, M. D. & Carapetis, J. R. The microbiology of impetigo in Indigenous children: associations between Streptococcus pyogenes, Staphylococcus aureus, scabies, and nasal carriage. BMC Infect. Dis. 14, 727 (2014).
pubmed: 25551178
pmcid: 4299569
doi: 10.1186/s12879-014-0727-5
Thean, L. J. et al. Prevention of bacterial complications of scabies using mass drug administration: a population-based, before-after trial in Fiji, 2018–2020. Lancet Reg. Health West. Pac. 22, 100433 (2022).
pubmed: 35345391
pmcid: 8956868
Bernigaud, C. et al. First description of the composition and the functional capabilities of the skin microbial community accompanying severe scabies infestation in humans. Microorganisms 9, 907 (2021).
pubmed: 33922793
pmcid: 8146700
doi: 10.3390/microorganisms9050907
Swe, P. M., Zakrzewski, M., Kelly, A., Krause, L. & Fischer, K. Scabies mites alter the skin microbiome and promote growth of opportunistic pathogens in a porcine model. PLoS Negl. Trop. Dis. 8, e2897 (2014). This paper describes in vivo experimental evidence in a longitudinal preclinical study to demonstrate that scabies mites drastically alter the healthy skin microbiota and promote the growth of pathogens.
pubmed: 24875186
pmcid: 4038468
doi: 10.1371/journal.pntd.0002897
McDonald, M. I. et al. Low rates of streptococcal pharyngitis and high rates of pyoderma in Australian aboriginal communities where acute rheumatic fever is hyperendemic. Clin. Infect. Dis. 43, 683–689 (2006).
pubmed: 16912939
doi: 10.1086/506938
Williamson, D. A. et al. M-protein analysis of Streptococcus pyogenes isolates associated with acute rheumatic fever in New Zealand. J. Clin. Microbiol. 53, 3618–3620 (2015).
pubmed: 26292296
pmcid: 4609735
doi: 10.1128/JCM.02129-15
Wyber, R., Bowen, A. C., Ralph, A. P. & Peiris, D. Primary prevention of acute rheumatic fever. Aust. J. Gen. Pract. 50, 265–269 (2021).
pubmed: 33928273
doi: 10.31128/AJGP-02-21-5852
Francis, J. R. et al. A cluster of acute rheumatic fever cases among Aboriginal Australians in a remote community with high baseline incidence. Aust. N. Z. J. Public Health 43, 288–293 (2019).
pubmed: 30994967
doi: 10.1111/1753-6405.12893
Steer, A. C. et al. High burden of impetigo and scabies in a tropical country. PLoS Negl. Trop. Dis. 3, e467 (2009).
pubmed: 19547749
pmcid: 2694270
doi: 10.1371/journal.pntd.0000467
Lin, S., Farber, J. & Lado, L. A case report of crusted scabies with methicillin-resistant Staphylococcus aureus bacteremia. J. Am. Geriatr. Soc. 57, 1713–1714 (2009).
pubmed: 19895437
doi: 10.1111/j.1532-5415.2009.02412.x
Mulholland, E. K. et al. Etiology of serious infections in young Gambian infants. Pediatr. Infect. Dis. 18, S35–S41 (1999).
doi: 10.1097/00006454-199910001-00007
Tong, S. Y., Varrone, L., Chatfield, M. D., Beaman, M. & Giffard, P. M. Progressive increase in community-associated methicillin-resistant Staphylococcus aureus in Indigenous populations in northern Australia from 1993 to 2012. Epidemiol. Infect. 143, 1519–1523 (2015).
pubmed: 25302939
doi: 10.1017/S0950268814002611
Engelman, D. et al. The 2020 International Alliance for the Control of Scabies consensus criteria for the diagnosis of scabies. Br. J. Dermatol. 183, 808–820 (2020).
pubmed: 32034956
pmcid: 7687112
doi: 10.1111/bjd.18943
Lavery, M. J., Stull, C., Kinney, M. O. & Yosipovitch, G. Nocturnal pruritus: the battle for a peaceful night’s sleep. Int. J. Mol. Sci. 17, 425 (2016).
pubmed: 27011178
pmcid: 4813276
doi: 10.3390/ijms17030425
Patel, T., Ishiuji, Y. & Yosipovitch, G. Nocturnal itch: why do we itch at night. Acta Derm. Venereol. 87, 295–298 (2007).
pubmed: 17598030
doi: 10.2340/00015555-0280
Podder, I., Mondal, H. & Kroumpouzos, G. Nocturnal pruritus and sleep disturbance associated with dermatologic disorders in adult patients. Int. J. Womens Dermatol. 7, 403–410 (2021).
pubmed: 34632036
pmcid: 8484989
doi: 10.1016/j.ijwd.2021.02.010
Chosidow, O. Scabies. N. Engl. J. Med. 354, 1718–1727 (2006).
pubmed: 16625010
doi: 10.1056/NEJMcp052784
Mason, D. S. et al. The prevalence of scabies and impetigo in the Solomon Islands: a population-based survey. PLoS Negl. Trop. Dis. 10, e0004803 (2016).
pubmed: 27348119
pmcid: 4922659
doi: 10.1371/journal.pntd.0004803
Hengge, U. R., Currie, B. J., Jager, G., Lupi, O. & Schwartz, R. A. Scabies: a ubiquitous neglected skin disease. Lancet Infect. Dis. 6, 769–779 (2006).
pubmed: 17123897
doi: 10.1016/S1473-3099(06)70654-5
Ostlere, L. S., Harris, D. & Rustin, M. H. Scabies associated with a bullous pemphigoid-like eruption. Br. J. Dermatol. 128, 217–219 (1993).
pubmed: 8457457
doi: 10.1111/j.1365-2133.1993.tb15155.x
Grodner, C. et al. Crusted scabies in children in France: a series of 20 cases. Eur. J. Pediatr. 181, 1167–1174 (2022).
pubmed: 34782946
doi: 10.1007/s00431-021-04251-4
Thompson, M. J., Engelman, D., Gholam, K., Fuller, L. C. & Steer, A. C. Systematic review of the diagnosis of scabies in therapeutic trials. Clin. Exp. Dermatol. 42, 481–487 (2017).
pubmed: 28556185
doi: 10.1111/ced.13152
Brenaut, E., Garlantezec, R., Talour, K. & Misery, L. Itch characteristics in five dermatoses: non-atopic eczema, atopic dermatitis, urticaria, psoriasis and scabies. Acta Derm. Venereol. 93, 573–574 (2013).
pubmed: 23722181
doi: 10.2340/00015555-1599
Sunderkötter, C., Wohlrab, J. & Hamm, H. Scabies: epidemiology, diagnosis, and treatment. Dtsch Arztebl Int. 118, 695–704 (2021).
pubmed: 34615594
pmcid: 8743988
Osti, M. H. et al. The diagnosis of scabies by non-expert examiners: a study of diagnostic accuracy. PLoS Negl. Trop. Dis. 13, e0007635 (2019).
pubmed: 31425513
pmcid: 6715246
doi: 10.1371/journal.pntd.0007635
Yari, N., Malone, C. H. & Rivas, A. Misdiagnosed crusted scabies in an AIDS patient leads to hyperinfestation. Cutis 99, 202–204 (2017).
pubmed: 28398415
Fonseca, V., Price, H. N., Jeffries, M., Alder, S. L. & Hansen, R. C. Crusted scabies misdiagnosed as erythrodermic psoriasis in a 3-year-old girl with Down syndrome. Pediatr. Dermatol. 31, 753–754 (2014).
pubmed: 24138478
doi: 10.1111/pde.12225
de Beer, G., Miller, M. A., Tremblay, L. & Monette, J. An outbreak of scabies in a long-term care facility: the role of misdiagnosis and the costs associated with control. Infect. Control. Hosp. Epidemiol. 27, 517–518 (2006).
pubmed: 16671037
doi: 10.1086/504365
Trettin, B., Amstrup Lassen, J., Andersen, F. & Agerskov, H. The journey of having scabies — a qualitative study. J. Nurs. Educ. Pract. https://doi.org/10.5430/jnep.v9n2p1 (2019).
Siddig, E. E. & Hay, R. Laboratory-based diagnosis of scabies: a review of the current status. Trans. R. Soc. Trop. Med. Hyg. 116, 4–9 (2022).
pubmed: 33763705
doi: 10.1093/trstmh/trab049
Marks, M. et al. Diagnostics to support the control of scabies-development of two target product profiles. PLoS Negl. Trop. Dis. 16, e0010556 (2022).
pubmed: 36040928
pmcid: 9467343
doi: 10.1371/journal.pntd.0010556
Shin, K. et al. Clinical characteristics of pruritus in scabies. Indian J. Dermatol. Venereol. Leprol. 83, 492–492 (2017).
pubmed: 28540869
doi: 10.4103/ijdvl.IJDVL_1136_16
Engelman, D., Fuller, L. C., Steer, A. C. & International Alliance for the Control of Scabies Delphi Panel. Consensus criteria for the diagnosis of scabies: a Delphi study of international experts. PLoS Negl. Trop. Dis. 12, e0006549 (2018).
pubmed: 29795566
pmcid: 5991412
doi: 10.1371/journal.pntd.0006549
Walker, S. L. et al. A community-based validation of the International Alliance for the Control of Scabies Consensus Criteria by expert and non-expert examiners in Liberia. PLoS Negl. Trop. Dis. 14, e0008717 (2020).
pubmed: 33017426
pmcid: 7732067
doi: 10.1371/journal.pntd.0008717
Leung, V. & Miller, M. Detection of scabies: a systematic review of diagnostic methods. Can. J. Infect. Dis. Med. Microbiol. 22, 698494 (2011).
doi: 10.1155/2011/698494
Micali, G., Lacarrubba, F., Verzì, A. E., Chosidow, O. & Schwartz, R. A. Scabies: advances in noninvasive diagnosis. PLoS Negl. Trop. Dis. 10, e0004691 (2016).
pubmed: 27311065
pmcid: 4911127
doi: 10.1371/journal.pntd.0004691
Cinotti, E. et al. Videodermoscopy compared to reflectance confocal microscopy for the diagnosis of scabies. J. Eur. Acad. Dermatol. Venereol. 30, 1573–1577 (2016).
pubmed: 27168425
doi: 10.1111/jdv.13676
Ruini, C. et al. In vivo imaging of Sarcoptes scabiei infestation using line-field confocal optical coherence tomography. J. Eur. Acad. Dermatol. Venereol. 34, e808–e809 (2020).
pubmed: 32455490
doi: 10.1111/jdv.16671
Rider, S. D., Morgan, M. S. & Arlian, L. G. Draft genome of the scabies mite. Vectors 8, 585 (2015).
doi: 10.1186/s13071-015-1198-2
Jayaraj, R. et al. A diagnostic test for scabies: IgE specificity for a recombinant allergen of Sarcoptes scabiei. Diagn. Microbiol. Infect. Dis. 71, 403–407 (2011).
pubmed: 22018936
doi: 10.1016/j.diagmicrobio.2011.09.007
He, R. et al. Molecular characterization and allergenicity potential of triosephosphate isomerase from Sarcoptes scabiei. Vet. Parasitol. 257, 40–47 (2018).
pubmed: 29907191
doi: 10.1016/j.vetpar.2018.05.016
Shen, N. et al. Expression and characterisation of a Sarcoptes scabiei protein tyrosine kinase as a potential antigen for scabies diagnosis. Sci. Rep. 7, 9639 (2017).
pubmed: 28852108
pmcid: 5575040
doi: 10.1038/s41598-017-10326-w
He, R. et al. Molecular characterization of calmodulin from Sarcoptes scabiei. Parasitol. Int. 66, 1–6 (2017).
pubmed: 27840198
doi: 10.1016/j.parint.2016.11.005
Shen, N. et al. A chitinase-like protein from Sarcoptes scabiei as a candidate anti-mite vaccine that contributes to immune protection in rabbits. Parasit. Vectors 11, 599 (2018).
pubmed: 30454025
pmcid: 6245717
doi: 10.1186/s13071-018-3184-y
Chng, L. et al. Molecular diagnosis of scabies using a novel probe-based polymerase chain reaction assay targeting high-copy number repetitive sequences in the Sarcoptes scabiei genome. PLoS Negl. Trop. Dis. 15, e0009149 (2021).
pubmed: 33626043
pmcid: 7939366
doi: 10.1371/journal.pntd.0009149
Delaunay, P. et al. Scabies polymerase chain reaction with standardized dry swab sampling: an easy tool for cluster diagnosis of human scabies. Br. J. Dermatol. 182, 197–201 (2020).
pubmed: 31004505
Fraser, T. A. et al. A Sarcoptes scabiei specific isothermal amplification assay for detection of this important ectoparasite of wombats and other animals. PeerJ 6, e5291 (2018).
pubmed: 30065882
pmcid: 6065476
doi: 10.7717/peerj.5291
Naz, S., Rizvi, D. A., Javaid, A., Ismail, M. & Chaudhry, F. R. Validation of PCR assay for identification of Sarcoptes scabiei var. hominis. Iran. J. Parasitol. 8, 437–440 (2013).
pubmed: 24454438
pmcid: 3887246
Bharadwaj, M., Bengtson, M., Golverdingen, M., Waling, L. & Dekker, C. Diagnosing point-of-care diagnostics for neglected tropical diseases. PLoS Negl. Trop. Dis. 15, e0009405 (2021).
pubmed: 34138846
pmcid: 8211285
doi: 10.1371/journal.pntd.0009405
Neglected tropical diseases. WHO https://www.who.int/news-room/questions-and-answers/item/neglected-tropical-diseases (WHO, 2023).
World Health Organization. Ending the Neglect to Attain the Sustainable Development Goals: A Road Map for Neglected Tropical Diseases 2021–2030 (WHO, 2021).
Mahé, A. et al. Integration of basic dermatological care into primary health care services in Mali. Bull. World Health Organ. 83, 935–941 (2005).
pubmed: 16462986
Estrada, R., Chavez-Lopez, G., Estrada-Chavez, G. & Paredes-Solis, S. Specialized dermatological care for marginalized populations and education at the primary care level: is community dermatology a feasible proposal. Int. J. Dermatol. 51, 1345–1350 (2012).
pubmed: 23067084
doi: 10.1111/j.1365-4632.2012.05546.x
Micali, G., Lacarrubba, F., Verzi, A. E. & Nasca, M. R. Low-cost equipment for diagnosis and management of endemic scabies outbreaks in underserved populations. Clin. Infect. Dis. 60, 327–329 (2015).
pubmed: 25344538
doi: 10.1093/cid/ciu826
Romani, L. et al. Mass drug administration for scabies control in a population with endemic disease. N. Engl. J. Med. 373, 2305–2313 (2015).
pubmed: 26650152
doi: 10.1056/NEJMoa1500987
Bernigaud, C. et al. How to eliminate scabies parasites from fomites: a high-throughput ex vivo experimental study. J. Am. Acad. Dermatol. 83, 241–245 (2020). Statistically standardized experimental data validating real-life decontamination modalities for scabies, applicable in settings without electricity, to develop clear and simple directions for scabies outbreaks.
pubmed: 31857110
doi: 10.1016/j.jaad.2019.11.069
Currie, B. J. Scabies and global control of neglected tropical diseases. N. Engl. J. Med. 373, 2371–2372 (2015).
pubmed: 26650157
doi: 10.1056/NEJMe1511805
Scabies. WHO https://www.who.int/news-room/fact-sheets/detail/scabies (2023).
Lake, S. J. et al. Mass drug administration for the control of scabies: a systematic review and meta-analysis. Clin. Infect. Dis. 75, 959–967 (2022).
pubmed: 35088849
pmcid: 9522411
doi: 10.1093/cid/ciac042
Fernando, D. D. & Fischer, K. Spinosad topical suspension (0.9%): a new topical treatment for scabies. Expert. Rev. Anti Infect. Ther. 20, 1149–1154 (2022).
pubmed: 35799317
doi: 10.1080/14787210.2022.2099376
Currie, B. J. & McCarthy, J. S. Permethrin and ivermectin for scabies. N. Engl. J. Med. 362, 717–725 (2010).
pubmed: 20181973
doi: 10.1056/NEJMct0910329
Bernigaud, C. et al. In vitro ovicidal activity of current and under‐development scabicides: which treatments kill scabies eggs? Br. J. Dermatol. 182, 511–513 (2020). This paper discusses systematic and comprehensive testing of all available drugs in use to treat scabies in humans, confirming that the most used drugs to treat scabies are indeed not ovicidal.
pubmed: 31508811
doi: 10.1111/bjd.18517
Bernigaud, C. et al. Efficacy and pharmacokinetics evaluation of a single oral dose of afoxolaner against Sarcoptes scabiei in the porcine scabies model for human infestation. Antimicrob. Agents Chemother. 62, e02334-17 (2018).
pubmed: 29914951
pmcid: 6125498
doi: 10.1128/AAC.02334-17
Nolan, K., Kamrath, J. & Levitt, J. Lindane toxicity: a comprehensive review of the medical literature. Pediatr. Dermatol. 29, 141–146 (2012).
pubmed: 21995612
doi: 10.1111/j.1525-1470.2011.01519.x
Singh, B., Kaur, J. & Singh, K. Microbial degradation of an organophosphate pesticide, malathion. Crit. Rev. Microbiol. 40, 146–154 (2014).
pubmed: 23442144
doi: 10.3109/1040841X.2013.763222
Strong, M. & Johnstone, P. Interventions for treating scabies. Cochrane Database Syst. Rev. 3, CD000320 (2007).
Rosumeck, S., Nast, A. & Dressler, C. Ivermectin and permethrin for treating scabies. Cochrane Database Syst. Rev. 4, CD012994 (2018).
pubmed: 29608022
US National Library of Medicine. ClinicalTrials.gov https://clinicaltrials.gov/study/NCT02407782 (2015).
Thadanipon, K., Anothaisintawee, T., Rattanasiri, S., Thakkinstian, A. & Attia, J. Efficacy and safety of antiscabietic agents: a systematic review and network meta-analysis of randomized controlled trials. J. Am. Acad. Dermatol. 80, 1435–1444 (2019).
pubmed: 30654070
doi: 10.1016/j.jaad.2019.01.004
Bernigaud, C., Samarawickrama, G. R., Jones, M. K., Gasser, R. B. & Fischer, K. The challenge of developing a single-dose treatment for scabies. Trends Parasitol. 35, 931–943 (2019).
pubmed: 31474559
doi: 10.1016/j.pt.2019.08.002
Seiler, J. C. et al. Spinosad at 0.9% in the treatment of scabies: efficacy results from 2 multicenter, randomized, double-blind, vehicle-controlled studies. J. Am. Acad. Dermatol. 86, 97–103 (2022).
pubmed: 34391812
doi: 10.1016/j.jaad.2021.07.074
US National Library of Medicine. ClinicalTrials.gov https://www.clinicaltrials.gov/study/NCT05875441?cond=scabies&rank=8 (2023).
US National Library of Medicine. ClinicalTrials.gov https://www.clinicaltrials.gov/study/NCT03905265?cond=scabies&page=2&rank=12 (2023).
Weill, A. et al. Scabies-infested pregnant women: a critical therapeutic challenge. PLoS Negl. Trop. Dis. 15, e0008929 (2021).
pubmed: 33411710
pmcid: 7790223
doi: 10.1371/journal.pntd.0008929
Levy, M. et al. Ivermectin safety in infants and children under 15 kg treated for scabies: a multicentric observational study. Br. J. Dermatol. 182, 1003–1006 (2020).
pubmed: 31344258
doi: 10.1111/bjd.18369
Jittamala, P. et al. Correction: a systematic review and an individual patient data meta-analysis of ivermectin use in children weighing less than fifteen kilograms: is it time to reconsider the current contraindication? PLoS Negl. Trop. Dis. 17, e0011053 (2023).
pubmed: 36607893
pmcid: 9821483
doi: 10.1371/journal.pntd.0011053
Davis, J. S., McGloughlin, S., Tong, S. Y., Walton, S. F. & Currie, B. J. A novel clinical grading scale to guide the management of crusted scabies. PLoS Negl. Trop. Dis. 7, e2387 (2013).
pubmed: 24069468
pmcid: 3772049
doi: 10.1371/journal.pntd.0002387
Kim, H. S. et al. Scabies itch: an update on neuroimmune interactions and novel targets. J. Eur. Acad. Dermatol. Venereol. 35, 1765–1776 (2021).
pubmed: 33960033
doi: 10.1111/jdv.17334
Bowen, A. C. et al. Short-course oral co-trimoxazole versus intramuscular benzathine benzylpenicillin for impetigo in a highly endemic region: an open-label, randomised, controlled, non-inferiority trial. Lancet 384, 2132–2140 (2014).
pubmed: 25172376
doi: 10.1016/S0140-6736(14)60841-2
Hotez, P. J., Fenwick, A., Ray, S. E., Hay, S. I. & Molyneux, D. H. “Rapid impact” 10 years after: the first “decade” (2006–2016) of integrated neglected tropical disease control. PLoS Negl. Trop. Dis. 12, e0006137 (2018).
pubmed: 29795551
pmcid: 5967703
doi: 10.1371/journal.pntd.0006137
Taplin, D. et al. Community control of scabies: a model based on use of permethrin cream. Lancet 337, 1016–1018 (1991).
pubmed: 1673175
doi: 10.1016/0140-6736(91)92669-S
Engelman, D. et al. A framework for scabies control. PLoS Negl. Trop. Dis. 15, e0009661 (2021).
pubmed: 34473725
pmcid: 8412357
doi: 10.1371/journal.pntd.0009661
Mounsey, K. E., Bernigaud, C., Chosidow, O. & McCarthy, J. S. Prospects for moxidectin as a new oral treatment for human scabies. PLoS Negl. Trop. Dis. 10, e0004389 (2016).
pubmed: 26985995
pmcid: 4795782
doi: 10.1371/journal.pntd.0004389
Elsner, E., Uhlmann, T., Krause, S. & Hartmann, R. Increase of scabies and therapy resistance among German military personnel : an 8-year follow-up study in the Department of Dermatology of the Armed Forces Hospital Berlin, Germany (2012-2019) [German]. Hautarzt 71, 447–454 (2020).
pubmed: 32430543
doi: 10.1007/s00105-020-04608-0
Hackenberg, B. et al. Scabies therapy in Germany : results of a nationwide survey with a special focus on the efficacy of first-line therapy with permethrin [German]. Hautarzt 71, 374–379 (2020).
pubmed: 32144440
doi: 10.1007/s00105-020-04561-y
Sunderkötter, C. et al. Increase of scabies in Germany and development of resistant mites? Evidence and consequences. J. Dtsch. Dermatol. Ges. 17, 15–23 (2019).
pubmed: 30615283
Mang, R., Kremer, A., Lehmann, P. & Assmann, T. Scabies-clinical resistance to permethrin therapy : case reports and a critical discussion of current treatment recommendations [German]. Hautarzt 72, 595–599 (2021).
pubmed: 33721046
doi: 10.1007/s00105-021-04783-8
Meyersburg, D., Kaiser, A. & Bauer, J. W. Loss of efficacy of topical 5% permethrin for treating scabies: an Austrian single-center study. J. Dermatol. Treat. 33, 774–777 (2022).
doi: 10.1080/09546634.2020.1774489
Balestri, R. et al. Scabies is becoming less sensitive to permethrin therapy. J. Eur. Acad. Dermatol. Venereol. 35, e889–e891 (2021).
pubmed: 34310767
doi: 10.1111/jdv.17538
Mazzatenta, C., Piccolo, V., Argenziano, G. & Bassi, A. Is scabies becoming less sensitive to permethrin therapy? J. Eur. Acad. Dermatol. Venereol. 35, e607–e609 (2021).
pubmed: 33974300
doi: 10.1111/jdv.17339
Coleman, H. & Sethi, G. C. Treatment failure in scabies: a single-centre 5-year retrospective review. Sex. Transm. Infect. https://doi.org/10.1136/sextrans-2023-055949 (2023).
doi: 10.1136/sextrans-2023-055949
pubmed: 36396175
Nemecek, R., Stockbauer, A., Lexa, M., Poeppl, W. & Mooseder, G. Application errors associated with topical treatment of scabies: an observational study. J. Dtsch Dermatol. Ges. 18, 554–559 (2020).
pubmed: 32519488
Riebenbauer, K. et al. Detection of a knockdown mutation in the voltage-sensitive sodium channel associated with permethrin tolerance in Sarcoptes scabiei var. hominis mites. J. Eur. Acad. Dermatol. Venereol. 37, 2355–2361 (2023).
pubmed: 37356045
doi: 10.1111/jdv.19288
Veraldi, S., Schianchi, R., Silvio, M. & Aromolo, I. F. Pseudoresistance to permethrin in scabies. J. Infect. Dev. Ctries 17, 713–715 (2023).
pubmed: 37279414
doi: 10.3855/jidc.17750
Pasay, C. et al. The effect of insecticide synergists on the response of scabies mites to pyrethroid acaricides. PLoS Negl. Trop. Dis. 3, e354 (2009).
pubmed: 19125173
pmcid: 2603020
doi: 10.1371/journal.pntd.0000354
Pasay, C., Walton, S., Fischer, K., Holt, D. & McCarthy, J. PCR-based assay to survey for knockdown resistance to pyrethroid acaricides in human scabies mites (Sarcoptes scabiei var hominis). Am. J. Trop. Med. Hyg. 74, 649–657 (2006).
pubmed: 16607000
doi: 10.4269/ajtmh.2006.74.649
Yürekli, A. Is there a really resistance to scabies treatment with permethrin? In vitro killing activity of permethrin on Sarcoptes scabiei from patients with resistant scabies. Dermatol. Ther. 35, e15260 (2022).
pubmed: 34897912
doi: 10.1111/dth.15260
Fang, F. et al. Efficacy assessment of biocides or repellents for the control of Sarcoptes scabiei in the environment. Parasit. Vectors 8, 416 (2015).
pubmed: 26259713
pmcid: 4531531
doi: 10.1186/s13071-015-1027-7
Pallesen, K. et al. In vitro survival of scabies mites. Clin. Exp. Dermatol. 45, 712–715 (2020).
pubmed: 32112428
doi: 10.1111/ced.14209
Fujimoto, K., Kawasaki, Y., Morimoto, K., Kikuchi, I. & Kawana, S. Treatment for crusted scabies: limitations and side effects of treatment with Ivermectin. J. Nippon. Med. Sch. 81, 157–163 (2014).
pubmed: 24998962
doi: 10.1272/jnms.81.157
Currie, B. J., Harumal, P., McKinnon, M. & Walton, S. F. First documentation of in vivo and in vitro ivermectin resistance in Sarcoptes scabiei. Clin. Infect. Dis. 39, e8–e12 (2004).
pubmed: 15206075
doi: 10.1086/421776
Mounsey, K. E., Holt, D. C., McCarthy, J. S., Currie, B. J. & Walton, S. F. Longitudinal evidence of increasing in vitro tolerance of scabies mites to ivermectin in scabies-endemic communities. Arch. Dermatol. 145, 840–841 (2009).
pubmed: 19620572
doi: 10.1001/archdermatol.2009.125
Mounsey, K. E. et al. Increased transcription of Glutathione S-transferases in acaricide exposed scabies mites. Parasit. Vectors 3, 43 (2010).
pubmed: 20482766
pmcid: 2890653
doi: 10.1186/1756-3305-3-43
Chang, A. Y. & Heukelbach, J. In: Scabies (eds Fischer, K. & Chosidow, O.) 471-482 (Springer, 2023).
Krotneva, S. P. et al. African program for onchocerciasis control 1995-2010: impact of annual ivermectin mass treatment on off-target infectious diseases. PLoS Negl. Trop. Dis. 9, e0004051 (2015).
pubmed: 26401658
pmcid: 4581698
doi: 10.1371/journal.pntd.0004051
Kearns, T. M. et al. Strongyloides seroprevalence before and after an ivermectin mass drug administration in a remote Australian Aboriginal community. PLoS Negl. Trop. Dis. 11, e0005607 (2017).
pubmed: 28505198
pmcid: 5444847
doi: 10.1371/journal.pntd.0005607
Mohammed, K. A., Deb, R. M., Stanton, M. C. & Molyneux, D. H. Soil transmitted helminths and scabies in Zanzibar, Tanzania following mass drug administration for lymphatic filariasis-a rapid assessment methodology to assess impact. Parasit. Vectors 5, 299 (2012).
pubmed: 23259465
pmcid: 3543323
doi: 10.1186/1756-3305-5-299
Martin, D. et al. Impact of ivermectin mass drug administration for lymphatic filariasis on scabies in eight villages in Kongwa District, Tanzania. Am. J. Trop. Med. Hyg. 99, 937–939 (2018).
pubmed: 30062986
pmcid: 6159570
doi: 10.4269/ajtmh.18-0018
Heukelbach, J. et al. Selective mass treatment with ivermectin to control intestinal helminthiases and parasitic skin diseases in a severely affected population. Bull. World Health Organ. 82, 563–571 (2004).
pubmed: 15375445
pmcid: 2622929
Chosidow, O. & Fuller, L. C. Scratching the itch: is scabies a truly neglected disease. Lancet Infect. Dis. 17, 1220–1221 (2017).
pubmed: 28941562
doi: 10.1016/S1473-3099(17)30469-3
Lake, S. J. et al. Health-related quality of life impact of scabies in the Solomon Islands. Trans. R. Soc. Trop. Med. Hyg. 116, 148–156 (2022).
pubmed: 34182575
doi: 10.1093/trstmh/trab096
Karadoğan, S. K. & Altay, B. U. Dermatology Quality of Life and Depression, Anxiety, and Stress-42 scale in scabies patients. Dermatol. pract. concept. 14, e2024112 (2024).
pubmed: 38810073
pmcid: 11135924
doi: 10.5826/dpc.1402a112
Paudel, S., Pudasaini, P., Adhikari, S., Pradhan, M. B. & Shekhar Babu, K. C. Quality of life in patients with scabies: a cross-sectional study using Dermatology Life Quality Index (DLQI) questionnaire. JEADV Clin. Pract. 2, 399–403 (2023).
doi: 10.1002/jvc2.127
Jin-gang, A. et al. Quality of life of patients with scabies. J. Eur. Acad. Dermatol. Venereol. 24, 1187–1191 (2010).
pubmed: 20236379
doi: 10.1111/j.1468-3083.2010.03618.x
Nair, P. A., Vora, R. V., Jivani, N. B. & Gandhi, S. S. A study of clinical profile and quality of life in patients with scabies at a rural tertiary care centre. J. Clin. Diagn. Res. 10, WC01–WC05 (2016).
pubmed: 27891435
pmcid: 5121773
Worth, C. et al. Impaired quality of life in adults and children with scabies from an impoverished community in Brazil. Int. J. Dermatol. 51, 275–282 (2012).
pubmed: 22348561
doi: 10.1111/j.1365-4632.2011.05017.x
Mohammed Ali, K. B., Othman, S. M. & Asaad, Y. A. Quality of life in patients with scabies in Erbil, Iraq. Zanco J. Med. Sci. 25, 638–648 (2021).
doi: 10.15218/zjms.2021.030
Koc Yildirim, S., Demirel Ogut, N., Erbagci, E. & Ogut, C. Scabies affects quality of life in correlation with depression and anxiety. Dermatol. Pract. Concept. 13, e2023144 (2023).
pubmed: 37196304
pmcid: 10188156
doi: 10.5826/dpc.1302a144
Menaldi, S. L. S. W., Surya, D., The, V. V. & Marissa, M. Impact of scabies on Indonesian public boarding school students’ quality of life: a mixed-method analysis. J. Gen. Proced. Dermatol. Venereol. Indones. https://doi.org/10.19100/jdvi.v5i2.264 (2021).
Duran, S. & YÜReklİ, A. Determination of drug compliance and quality of life in individuals diagnosed with scabies. Karya J. Health Sci. 4, 6–10 (2023).
doi: 10.52831/kjhs.1168654
Korycinska, J., Dzika, E. & Kloch, M. Epidemiology of scabies in relation to socio-economic and selected climatic factors in north-east Poland. Ann. Agric. Env. Med. 27, 374–378 (2020).
doi: 10.26444/aaem/109319
Chowdhry, S., Sheoran, P., D’souza, P., Yadav, M. K. & Rathore, S. Assessment of the quality of life in patients with scabies in an urban tertiary care centre in North India. Serb. J. Dermatol. Venerol. 12, 41–46 (2020).
doi: 10.2478/sjdv-2020-0007
Balcı, D. D., Sangün, Ö. & İnandı, T. Cross validation of the Turkish version of children’s Dermatology Life Quality Index. J. Turk. Acad. Dermatol. 1, 71402a (2007).
Temel, B. et al. Evaluation of dermatology life quality index, depression-anxiety-stress scores of patients with genital dermatoses. Indian J. Dermatol. 68, 399–404 (2023).
pubmed: 37822383
pmcid: 10564216
doi: 10.4103/ijd.ijd_424_23
Makigami, K. et al. Risk factors for recurrence of scabies: a retrospective study of scabies patients in a long-term care hospital. J. Dermatol. 38, 874–879 (2011).
pubmed: 21658115
Hay, R. J. et al. Wastage of family income on skin disease in Mexico. BMJ 309, 848 (1994).
pubmed: 7950615
pmcid: 2541080
doi: 10.1136/bmj.309.6958.848
Campbell, M. et al. Health care cost of crusted scabies in Aboriginal communities in the Northern Territory, Australia. PLoS Negl. Trop. Dis. 16, e0010288 (2022).
pubmed: 35344551
pmcid: 8989313
doi: 10.1371/journal.pntd.0010288
Welch, E., Romani, L. & Whitfeld, M. J. Recent advances in understanding and treating scabies. Fac. Rev. 10, 28 (2021).
pubmed: 33817697
pmcid: 8009191
doi: 10.12703/r/10-28
El-Moamly, A. A. Scabies as a part of the World Health Organization roadmap for neglected tropical diseases 2021-2030: what we know and what we need to do for global control. Trop. Med. Health 49, 64 (2021).
pubmed: 34399850
pmcid: 8366162
doi: 10.1186/s41182-021-00348-6
Cox, V., Fuller, L. C., Engelman, D., Steer, A. & Hay, R. J. Estimating the global burden of scabies: what else do we need? Br. J. Dermatol. 184, 237–242 (2021).
pubmed: 32358799
doi: 10.1111/bjd.19170
Romani, L. et al. Efficacy of mass drug administration with ivermectin for control of scabies and impetigo, with coadministration of azithromycin: a single-arm community intervention trial. Lancet Infect. Dis. 19, 510–518 (2019).
pubmed: 30956111
pmcid: 6483975
doi: 10.1016/S1473-3099(18)30790-4
Romani, L. et al. Feasibility and safety of mass drug coadministration with azithromycin and ivermectin for the control of neglected tropical diseases: a single-arm intervention trial. Lancet Glob. Health 6, e1132–e1138 (2018).
pubmed: 30223985
pmcid: 6139784
doi: 10.1016/S2214-109X(18)30397-8
Chosidow, O. & Hay, R. J. Control of scabies and secondary impetigo: optimising treatment effectiveness in endemic settings. Lancet Infect. Dis. 19, 454–456 (2019).
pubmed: 30956112
doi: 10.1016/S1473-3099(19)30068-4
UKHSA guidance on the management of scabies cases and outbreaks in long-term care facilities and other closed settings. UKHSA https://www.gov.uk/government/publications/scabies-management-advice-for-health-professionals/ukhsa-guidance-on-the-management-of-scabies-cases-and-outbreaks-in-long-term-care-facilities-and-other-closed-settings (2023).
Marks, M. Why does treatment for scabies fail? J. Eur. Acad. Dermatol. Venereol. 38, 462–463 (2024).
pubmed: 38391211
doi: 10.1111/jdv.19786
Shelley, W. B., Shelley, E. D. & Burmeister, V. Staphylococcus aureus colonization of burrows in erythrodermic Norwegian scabies. A case study of iatrogenic contagion. J. Am. Acad. Dermatol. 19, 673–678 (1988).
pubmed: 2972758
doi: 10.1016/S0190-9622(88)70221-2
Shelley, W. B. & Shelley, E. D. Scanning electron microscopy of the scabies burrow and its contents, with special reference to the Sarcoptes scabiei egg. J. Am. Acad. Dermatol. 9, 673–679 (1983).
pubmed: 6417198
doi: 10.1016/S0190-9622(83)70179-9
Rapp, C. M., Morgan, M. S. & Arlian, L. G. Presence of host immunoglobulin in the gut of Sarcoptes scabiei (Acari: Sarcoptidae). J. Med. Entomol. 43, 539–542 (2006).
pubmed: 16739413
doi: 10.1093/jmedent/43.3.539
Willis, C., Fischer, K., Walton, S. F., Currie, B. J. & Kemp, D. J. Scabies mite inactivated serine protease paralogues are present both internally in the mite gut and externally in feces. Am. J. Trop. Med. Hyg. 75, 683–687 (2006).
pubmed: 17038694
doi: 10.4269/ajtmh.2006.75.683
Lambris, J. D., Ricklin, D. & Geisbrecht, B. V. Complement evasion by human pathogens. Nat. Rev. Microbiol. 6, 132–142 (2008).
pubmed: 18197169
pmcid: 2814840
doi: 10.1038/nrmicro1824
Arlian, L. G., Vyszenski-Moher, D. L. & Pole, M. J. Survival of adults and development stages of Sarcoptes scabiei var. canis when off the host. Exp. Appl. Acarol. 6, 181–187 (1989).
pubmed: 2496958
doi: 10.1007/BF01193978
Rodríguez-Cadenas, F., Carbajal-González, M. T., Fregeneda-Grandes, J. M., Aller-Gancedo, J. M. & Rojo-Vázquez, F. A. Clinical evaluation and antibody responses in sheep after primary and secondary experimental challenges with the mange mite Sarcoptes scabiei var. ovis. Vet. Immunol. Immunopathol. 133, 109–116 (2010).
pubmed: 19783311
doi: 10.1016/j.vetimm.2009.07.004
Tarigan, S. & Huntley, J. F. Failure to protect goats following vaccination with soluble proteins of Sarcoptes scabiei: evidence for a role for IgE antibody in protection. Vet. Parasitol. 133, 101–109 (2005).
pubmed: 16118041
doi: 10.1016/j.vetpar.2005.03.044
Zhang, R. et al. Characterization and evaluation of a Sarcoptes scabiei allergen as a candidate vaccine. Parasit. Vectors 5, 176 (2012).
pubmed: 22897929
pmcid: 3436858
doi: 10.1186/1756-3305-5-176
Van Neste, D. J. & Staquet, M. J. Similar epidermal changes in hyperkeratotic scabies of humans and pigs. Am. J. Dermatopathol. 8, 267–273 (1986).
pubmed: 2425653
doi: 10.1097/00000372-198606000-00018
Bernigaud, C. et al. Preclinical study of single-dose moxidectin, a new oral treatment for scabies: efficacy, safety, and pharmacokinetics compared to two-dose ivermectin in a porcine model. PLoS Negl. Trop. Dis. 10, e0005030 (2016). This trial adapted an existing veterinary drug for use against human scabies.
pubmed: 27732588
pmcid: 5061321
doi: 10.1371/journal.pntd.0005030
Mounsey, K. E. et al. Quantitative PCR-based genome size estimation of the astigmatid mites Sarcoptes scabiei, Psoroptes ovis and Dermatophagoides pteronyssinus. Parasit Vectors 5, 3 (2012).
pubmed: 22214472
pmcid: 3274472
doi: 10.1186/1756-3305-5-3
Mofiz, E. et al. Mitochondrial genome sequence of the scabies mite provides insight into the genetic diversity of individual scabies infections. PLoS Negl. Trop. Dis. 10, e0004384 (2016).
pubmed: 26872064
pmcid: 4752359
doi: 10.1371/journal.pntd.0004384
Fernando, D. D. et al. Gene silencing by RNA interference in Sarcoptes scabiei: a molecular tool to identify novel therapeutic targets. Parasit. Vectors 10, 289 (2017).
pubmed: 28601087
pmcid: 5466799
doi: 10.1186/s13071-017-2226-1
Fernando, D. D., Korhonen, P. K., Gasser, R. B. & Fischer, K. An RNA interference tool to silence genes in Sarcoptes scabiei eggs. Int. J. Mol. Sci. 23, 873 (2022).
pubmed: 35055058
pmcid: 8777771
doi: 10.3390/ijms23020873
Korhonen, P. K. et al. Evidence that transcriptional alterations in sarcoptes scabiei are under tight post-transcriptional (microRNA) control. Int. J. Mol. Sci. 23, 9719 (2022).
pubmed: 36077116
pmcid: 9456212
doi: 10.3390/ijms23179719
Mofiz, E. et al. Genomic resources and draft assemblies of the human and porcine varieties of scabies mites, Sarcoptes scabiei var. hominis and var. suis. GigaScience 5, 23 (2016).
pubmed: 27250856
pmcid: 4890329
doi: 10.1186/s13742-016-0129-2
Wang, T. et al. Proteomic analysis of Sarcoptes scabiei reveals that proteins differentially expressed between eggs and female adult stages are involved predominantly in genetic information processing, metabolism and/or host-parasite interactions. PLoS Negl. Trop. Dis. 16, e0010946 (2022).
pubmed: 36472966
pmcid: 9725168
doi: 10.1371/journal.pntd.0010946
Fischer, K. et al. Structural mechanisms of inactivation in scabies mite serine protease paralogues. J. Mol. Biol. 390, 635–645 (2009).
pubmed: 19427318
doi: 10.1016/j.jmb.2009.04.082
Taylor, S., Walther, D., Fernando, D. D., Swe-Kay, P. & Fischer, K. Investigating the antibacterial properties of prospective scabicides. Biomedicines 10, 3287 (2022).
pubmed: 36552044
pmcid: 9776028
doi: 10.3390/biomedicines10123287
Swe, P. M., Zakrzewski, M., Waddell, R., Sriprakash, K. S. & Fischer, K. High-throughput metagenome analysis of the Sarcoptes scabiei internal microbiota and in-situ identification of intestinal Streptomyces sp. Sci. Rep. 9, 11744 (2019).
pubmed: 31409870
pmcid: 6692375
doi: 10.1038/s41598-019-47892-0